Lin BY - Search Results

1

[Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer].

Yuan P, Xu Y, Ouyang T, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT, Li JF. Yuan P, et al. Among authors: lin by. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):282-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615284 Chinese.

2

Weekly paclitaxel improved pathologic response of primary chemotherapy compared with standard 3 weeks schedule in primary breast cancer.

Qi M, Li JF, Xie YT, Lu AP, Lin BY, Ouyang T. Qi M, et al. Among authors: lin by. Breast Cancer Res Treat. 2010 Aug;123(1):197-202. doi: 10.1007/s10549-010-1000-2. Epub 2010 Jun 26. Breast Cancer Res Treat. 2010. PMID: 20582466 Clinical Trial.

3

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.

Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. Xu Y, et al. Clin Cancer Res. 2005 Oct 15;11(20):7328-33. doi: 10.1158/1078-0432.CCR-05-0507. Clin Cancer Res. 2005. PMID: 16243804

4

BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.

Chen W, Pan K, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Lu Y, You W, Xie Y. Chen W, et al. Breast Cancer Res Treat. 2009 Sep;117(1):55-60. doi: 10.1007/s10549-008-0066-6. Epub 2008 May 30. Breast Cancer Res Treat. 2009. PMID: 18512148

5

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

Zhang J, Pei R, Pang Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Zhang J, et al. Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x. Epub 2011 May 26. Breast Cancer Res Treat. 2012. PMID: 21614564

6

Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer.

Zhang M, Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Zhang M, et al. Breast Cancer Res Treat. 2012 Feb;132(1):335-40. doi: 10.1007/s10549-011-1887-2. Epub 2011 Nov 25. Breast Cancer Res Treat. 2012. PMID: 22116506

7

Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.

Fan Z, Li J, Wang T, Xie Y, Fan T, Lin B, Ouyang T. Fan Z, et al. Breast. 2013 Dec;22(6):1161-5. doi: 10.1016/j.breast.2013.08.004. Epub 2013 Sep 27. Breast. 2013. PMID: 24080493 Free article.

8

Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer.

Liu Y, Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Liu Y, et al. BMC Cancer. 2015 Mar 28;15:194. doi: 10.1186/s12885-015-1203-3. BMC Cancer. 2015. PMID: 25884806 Free PMC article.

9

Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer.

Yuan H, Chen J, Liu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Yuan H, et al. Clin Cancer Res. 2015 Oct 1;21(19):4365-72. doi: 10.1158/1078-0432.CCR-14-3354. Epub 2015 May 15. Clin Cancer Res. 2015. PMID: 25979484

10

TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide-based neoadjuvant chemotherapy in operable primary breast cancer.

Wang Y, Xu Y, Chen J, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Wang Y, et al. Int J Cancer. 2016 Jan 15;138(2):489-96. doi: 10.1002/ijc.29715. Epub 2015 Aug 13. Int J Cancer. 2016. PMID: 26238069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters